PE firm Advent names its India API, CDMO platform as Cohance Lifesciences
The US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to […]
Month: November 2022
PE firm Advent names its India API, CDMO platform as Cohance Lifesciences
The US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to […]
PE firm Advent names its India API, CDMO platform as Cohance Lifesciences
The US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to […]
PE firm Advent names its India API, CDMO platform as Cohance Lifesciences
The US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to […]
PE firm Advent names its India API, CDMO platform as Cohance Lifesciences
The US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to […]
PE firm Advent names its India API, CDMO platform as Cohance Lifesciences
The US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to […]
PE firm Advent names its India API, CDMO platform as Cohance Lifesciences
The US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to […]
New device launched for diagnosing prostate cancer
CamPROBE may save vital time and money while reducing the risk of infection
GigaGen’s use of 2G UNicTM tech extended by ProteoNic
ProteoNic’s protein expression technology improves recombinant protein production
Webinar: Optimize Medicare Advantage Star Ratings with Star Intelligence
For Medicare Advantage (MA) organizations, the stakes are high in today’s increasingly competitive environment, where savvy consumers who are dissatisfied with their plan have no […]
It’s time to acknowledge America’s pandemic drinking problem
As a nation, let’s face our alcohol dependency head-on and have an honest discussion about the growing consumption trends.
Pfizer says RSV vaccine is effective at preventing severe illness in babies
Pfizer on Tuesday announced its maternal vaccine for RSV, administered during pregnancy, was effective at preventing infants from developing severe symptoms from birth through their […]
Pfizer Reports P-III (MATISSE) Trial Results of RSVpreF for the Treatment of Respiratory Syncytial Virus
Shots: The P-III (MATISSE) trial evaluated the efficacy, safety, and immunogenicity of RSVpreF (120µg) vs PBO in a ratio (1:1) in 7400 patients aged ≤49yrs. […]
JAK inhibitors increase risk of cardiovascular problems and cancer, warns PRAC
Patients 65 years or older, those with increased risk of cardiovascular disorders like heart attack or stroke, individuals who smoke or have for an extended […]
Treating Psoriasis with Aloe Vera
Psoriasis is a chronic, inflammatory skin disease that affects about one in 40 people, making it “one of the most frequent chronic skin diseases worldwide.” […]
Drug Solutions Podcast: Processing Equipment Trends
In this episode, Alivia Leon, assistant editor, speaks with Christian Dunne, director of global corporate business development, Chargepoint Technology, about current and future processing equipment […]
While DCTs get all the hype, some industry insiders say the future is a digital hybrid
Leaders at Veeva believe the wording around decentralized trials has been exaggerated, and that a bigger-picture outlook is important as the pandemic winds down.
Tuberculosis patients haven’t seen new treatments in four decades – now Merck and Gates MRI have teamed up to change that
The Bill & Melinda Gates Medical Research Institute’s clinical development leader talks about its new licensing deal with Merck.
BMS announces positive Reblozyl phase 3 results for MDS
Bristol Myers Squibb has announced positive topline results from its phase 3 trial of Reblozyl (luspatercept-aamt), the first erythroid maturation agent for first-line treatment of […]
Memo Therapeutics AG Entered into a Research and Development Collaboration Agreement with Ono to Discover Antibodies Against Immuno-Oncology Targets
Shots: MTx to receive an up front & research funding and is also eligible to receive clinical development and sales milestones along with royalties on […]
23andMe gets FDA go-ahead to provide pharmacogenetic reports on statin
The US FDA provided 510(k) clearance for 23andMe to provide drug information for simvastatin based on the genetics of users of the service.
Altasciences expands Missouri bioanalytical site to support preclinical and clinical studies
Altasciences is expanding its facility in Columbia, Missouri to provide bioanalytical services in support of preclinical and clinical studies conducted in the US.
ACRO answers decentralized trial questions to ease worries and increase uptake
The Association of Clinical Research Organizations (ACRO) has released a question and answer document to support the adoption of decentralized clinical trials (DCT).
Pfizer says maternal RSV shot gives strong protection to newborns
Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive trial of the shot used to protect newborns adding to […]
Dyne Therapeutics’ DYNE-251 Receives the US FDA’s Fast Track Designation for the Treatment of Duchenne Muscular Dystrophy
Shots: The US FDA has granted the FTD to DYNE-251 for DMD mutations amenable to exon 51 skipping. DYNE-251 is being studied in the P-I/II […]
Dyne Therapeutics’ DYNE-251 Receives the US FDA’s Fast Track Designation for the Treatment of Duchenne Muscular Dystrophy
Shots: The US FDA has granted the FTD to DYNE-251 for DMD mutations amenable to exon 51 skipping. DYNE-251 is being studied in the P-I/II […]
Nicox glaucoma drug works, but not as well as hoped
Nicox has had both good and bad news from a much-anticipated phase 3 trial of its glaucoma therapy candidate NCX 470. On the plus side […]
Interview: Sarah MacDonald, Author, The Cancer Channel
by MATTHEW HOLT I met Sarah MacDonald in the early 2000s. She is the ultimate extrovert who sings, cooks, maintains a huge circle of friends, […]
Autoimmune drug biotech HI-Bio unveils $120M to root out cellular drivers of disease
Human Immunology Bioscience aims to stand apart in autoimmune disease drug research with therapies that address cells at the root of a range of allergic […]
Awake craniotomy | Brain Tumor Surgery
Did you know that it is possible for a surgeon to conduct a brain tumor surgery while you are awake without causing any pain? This […]
Rehabilitation after Brain Tumor Surgery
Brain surgery can take a toll on your body and recovering from it can be difficult for you. You should keep in mind that every […]
Lilly deepens bonds with Purdue University with new funding round
Eli Lilly’s links to Purdue University go back a long way, and have been reinvigorated with $92.5 million in additional funding and renewed research collaborations. […]
Eucure Biopharma Subsidiary of Biocytogen Collaborated with ISU ABXIS to Develop Tri-Specific Antibodies Using YH003 Antibody Sequence
Shots: Eucure Biopharma to receive an up front & is also eligible to receive milestones along with royalties The collaboration enables ISU ABXIS to use […]
Financial trap could force GP partners to work through burnout
GP partners off work with burnout are being forced to consider returning to their job before they feel ready because of a yawning gap between […]
Brain Tumor Surgery: Types and Risk Factor
Surgery is one of the approaches used to tackle brain tumors. The term “surgery” may make you anxious and worried, but the procedure is safe […]
This Open Enrollment Season, Look Out for Health Insurance That Seems Too Good to Be True
It took nearly a year for Kelly Macauley to realize the health plan she bought while shopping for insurance coverage last October was not, in […]
What Looks Like Pot, Acts Like Pot, but Is Legal Nearly Everywhere? Meet Hemp-Derived Delta-9 THC
ST. LOUIS — It was not shocking that people listening to musicians covering Grateful Dead and Phish songs in October at a dive bar here […]
Medicare Fines for High Hospital Readmissions Drop, but 2,300 Facilities Are Still Penalized
The federal government has eased its annual punishments for hospitals with higher-than-expected readmission rates in an acknowledgment of the upheaval the covid-19 pandemic has caused, […]
What are the Treatments for a Brain Tumor?
After you have received a diagnosis of a brain tumor, the next course of action would be to find the most suitable treatment for yourself. […]
Identifying the Signs of Brain Tumor
Brain tumors are cancerous or non-cancerous growth of cells in the brain. Early diagnosis and timely intervention can help in tackling brain tumors. There are […]
Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol
In January 2020, the financial conglomerate Visa announced it was acquiring a relatively unknown startup, Plaid, for $5.3 billion. Corporate acquisitions like these are not […]
Antengene Receives the US FDA’s IND Clearance of ATG-017 to Initiate P-I (ERASER) Trial for Advanced Solid Tumors
Shots: The US FDA has cleared an IND application to initiate the P-I (ERASER) trial evaluating the safety, PK & preliminary efficacy of ATG-017 + […]
Antengene Receives the US FDA’s IND Clearance of ATG-017 to Initiate P-I (ERASER) Trial for Advanced Solid Tumors
Shots: The US FDA has cleared an IND application to initiate the P-I (ERASER) trial evaluating the safety, PK & preliminary efficacy of ATG-017 + […]
CPHI report predicts huge funding overhang to drive contract services growth
New research from the CPHI Annual Report 2022 – launched during CPHI Frankfurt (1-3 November, 2022) – predicts that huge volumes of Venture Capital (VC) […]
Ascendis Pharma Reports the US FDA’s Acceptance of NDA for Priority Review of TransCon PTH to Treat Hypoparathyroidism in Adult Patients
Shots: The US FDA has accepted the NDA of TransCon PTH (palopegteriparatide) for Priority Review in adult patients with hypoparathyroidism. The PDUFA date is expected […]
Ascendis Pharma Reports the US FDA’s Acceptance of NDA for Priority Review of TransCon PTH to Treat Hypoparathyroidism in Adult Patients
Shots: The US FDA has accepted the NDA of TransCon PTH (palopegteriparatide) for Priority Review in adult patients with hypoparathyroidism. The PDUFA date is expected […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
Alembic Pharma gets USFDA nod for generic version of Glycopyrrolate injection
Glycopyrrolate injection is also indicated for use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or […]
The world is getting safer
…well, at least fewer people are dying from natural disasters. This is from a recent New York Times article.
New tentative approval for Teva Pharms drug eltrombopag
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generic ingredient in two branded drugs marketed by Novartis and is included in two NDAs. There are eight patents protecting […]
New patent for Global Blood drug OXBRYTA
Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. There are nine patents […]
New tentative approval for Amneal Pharms drug saxagliptin
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generic ingredient in one branded drug marketed by Astrazeneca Ab and is included in one NDA. There are two patents […]
Which pharmaceutical companies have the most drug patents in Malaysia?
This chart shows the pharmaceutical companies with the most patents in Malaysia. Patents must be filed in each country (or, in some cases regional patent […]
CPHI Frankfurt: November 1 – 3, 2022
CPHI Frankfurt is a hybrid event discussing emerging trends and novel technologies in the pharmaceutical industry.
Why MDs (and Patients) Can’t Thrive without MDM and Protection
Alcyr Araujo, CEO and founder of Mosyle It’s no secret providers are increasingly reliant on mobile devices like cell phones, tablets, and laptops to improve […]
Trust is essential to a functioning social safety net: Lessons from the pandemic
The post Trust is essential to a functioning social safety net: Lessons from the pandemic appeared first on Healthy Debate.
National Advisory Committee on Occupational Safety and Health (NACOSH): Notice of Meetings
[Federal Register Volume 87, (Tuesday, November 1, 2022 )] [Notice] [Pages 65828-65829] National Advisory Committee on Occupational Safety and Health (NACOSH): Notice of Meetings
Apply & enroll in 2023 coverage today
Open Enrollment starts today! You have until January 15, 2023 to apply for new health coverage or change your health plan for 2023. If you […]
